Pharma major Glenmark Pharmaceuticals Ltd on Tuesday said it has launched a bioequivalent version of Tiotropium Bromide dry powder inhaler (DPI) under the brand name - Tiogiva, in UK for the treatment ...
Dublin, June 04, 2024 (GLOBE NEWSWIRE) -- The "Dry Powder Inhaler Global Market Report 2024" has been added to ResearchAndMarkets.com's offering. The dry powder inhaler market size has grown strongly ...
New Delhi, Jun 15 () Drug firm Glenmark Pharma on Tuesday announced the launch of Tiotropium Bromide Dry Powder Inhaler, used in the treatment of chronic obstructive pulmonary disease (COPD), in the ...
Dublin, Nov. 20, 2023 (GLOBE NEWSWIRE) -- The "Global Digital Dose Inhaler Market Analysis & Forecast to 2023-2033: Market By Product; By Type; By Application; and By Region" report has been added to ...
Glenmark Pharmaceuticals has launched a bioequivalent version of Tiotropium Bromide dry powder inhaler (DPI) under the brand name – Tiogiva, in the UK for the treatment of chronic obstructive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results